Alpha 1 Antitrypsin DeficiencyGeneticsRare diseaseChildren's health
What this study is
This is a long-term follow-up banking protocol that collects medical information and tissue (blood, liver and lung) samples for future research; use of data and samples for research purposes is overseen by the Tissue Bank Advisory Committee; the purpose of the Bank is to further research on alpha-1 antitrypsin deficiency.
Study details
- Sponsor
- University of Florida
- Conditions
- Alpha 1 Antitrypsin Deficiency
- Enrolling
- 5,000 people
- Starts
- 2002-12
- Est. completion
- 2033-06-10
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 0 Years – 100 YearsSex ALLHealthy volunteers AcceptedYou may qualify if
- All interested individuals may enroll
You can't join if
- There are no exclusion criteria
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openUniversity of Florida
Gainesville, Florida, United States
Study team
Sponsor
University of Florida
Study ID IRB201500842 AATD Tissue Bank
Principal investigator
Karina Serban, MD
University of Florida
Have questions? The record lists no central contact. Use Consider me and the site team can reach you, or find them through ClinicalTrials.gov ↗.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.